Filing metadata

Accession number
0001213900-25-014310
Form type
Form 4
Filer
Estrella Immunopharma, Inc.
CIK
CIK 1844417
Filed
Feb 14, 2025
Reporting period
Oct 30, 2024
Description
Insider transaction

Explore SEC Filings Hub